Tag: Bacillus Calmette-Guérin

Home / Bacillus Calmette-Guérin

Categories

First adenoviral vector-based gene therapy for high-risk Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer is approved by FDA

Jan 2023: The drug nadofaragene firadenovec-vncg (Adstiladrin, Ferring Pharmaceuticals) has been approved by the Food and Drug Administration for adult patients with high-risk, unresponsive non-muscle...
bacillus-calmette-guerin

Scan the code